Chen Guang Biological: The price of lutein is currently at a relatively low level and may rise in the future.

Chenguang Biotech disclosed in its investor relations activity record that the price of lutein is currently at a relatively low level and may rise in the future. Currently, raw material procurement prices have decreased, affecting the enthusiasm of farmers for planting. In the future, the company may breed its own varieties, develop planting bases, utilize raw material advantages to expand market share, enhance competitive advantages, and strive to achieve a state with a reasonable profit margin.